Advertisement

Radioimmunodetection and Radioimmunotherapy in Myosarcoma

  • A. Planting
  • J. Verweij
  • P. Cox
  • M. Pillay
  • G. Stoter
Conference paper

Abstract

Soft-tissue sarcomas account for approximately 1% of all malignancies. The treatment of choice is surgery, which is the only curative treatment for primary tumors of the trunk, head, and neck primaries. Initially, sarcomas of the limbs had to be treated with amputation, but since the discovery that adjuvant radiotherapy can prevent almost half of the local recurrence in sarcoma of the extremities [1, 2], limb-sparing surgery has become possible.

Keywords

Soft Tissue Sarcoma Tumor Deposit Extremity Soft Tissue Sarcoma Advanced Soft Tissue Sarcoma Total Body Scanning 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abbatucci JS, Boulier N, de Ranier J, Mandard AM, Tanguy A, Busson A (1984) Radiotherapy as an integrated part of the treatment of soft tissue sarcomas. Radiother Oncol 2: 115–121Google Scholar
  2. 2.
    Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, De Moss EV, Seipp C, Sindelar WF, Sugarbaker P, Wesley R (1982) The treatment of soft tissue sarcomas of the ex-tremities. Prospective randomized evaluation of (1) limb sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196: 305–315PubMedCrossRefGoogle Scholar
  3. 3.
    Rosenberg SA, Chang E, Glatstein E (1985) Adjuvant chemotherapy of extremity soft tissue sarcomas: review of National Cancer Institute experience. Cancer Treat Symp 3: 83–88Google Scholar
  4. 4.
    Edmonson JH, Fleming TR, Vins JCI, Omer Burgert E, Soule EH, O’Connell MJ, Sim FH, Ahmann DL (1984) Randomized study of systemic chemotherapy following complete excision of non-osseous sarcomas. J Clin Oncol 2: 1390–1396PubMedGoogle Scholar
  5. 5.
    Bramwell VHC (1986) Adjuvant chemotherapy for soft tissue sarcomas. In: Pinedo HM, Verweij J (eds) Clinical management of soft tissue sarcomas. Martinus Nijhoff, Boston, pp 89–101CrossRefGoogle Scholar
  6. 6.
    Yap BS, Sinkovics JG, Burgess MA, Benjamin RS, Bodey CP (1983) The curability of advanced soft tissue sarcomas in adults with chemotherapy. Proc ASCO abstr C-937, p 239Google Scholar
  7. 7.
    Pinedo HM, Bramwell VHC, Mouridsen HT, Somers R, Vendrik CPJ, Santoro A, Buesa J, Wagener T, v Oosterom AT, v Unnik JAM, Sylvester R, de Pauw M, Thomas D, Bonadonna G (1984) CYVADIC in advanced soft tissue sarcoma: a randomized study comparing two schedules. Cancer 53: 1852–1832Google Scholar
  8. 8.
    Verweij J, Pinedo HM (1986) Chemotherapy in advanced soft tissue sarcomas. In: Pinedo HM, Verweij J (eds) Clinical management of soft tissue sarcomas. Martinus Nijhoff, Boston, pp 81–88CrossRefGoogle Scholar
  9. 9.
    Köhler G, Milstein G (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497PubMedCrossRefGoogle Scholar
  10. 10.
    Kalofonos HP, Epenetos AA (1986) The role of monoclonal antibodies in tumor diagnosis. Cancer Treat Rev 13: 243–252PubMedCrossRefGoogle Scholar
  11. 11.
    Cox PH, Verweij J, Pillay M, Stoter G, Schönfeld D (1988) Indium-1ll antimyosin for the detection of leiomyosarcoma and rhabdomyosarcoma. Eur J Nucl Med 14: 50–52PubMedCrossRefGoogle Scholar
  12. 12.
    Lowder JN (1986) The current status of monoclonal antibodies in the diagnosis and therapy of cancer. Current problems in cancer 10: 502–507CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1989

Authors and Affiliations

  • A. Planting
    • 1
  • J. Verweij
    • 1
  • P. Cox
    • 1
  • M. Pillay
    • 1
  • G. Stoter
    • 1
  1. 1.Department of Medical OncologyRotterdam Cancer InstituteRotterdamThe Netherlands

Personalised recommendations